These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 19523795)

  • 1. Omega-3 fatty acids and dementia.
    Cole GM; Ma QL; Frautschy SA
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):213-21. PubMed ID: 19523795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
    Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association.
    Fotuhi M; Mohassel P; Yaffe K
    Nat Clin Pract Neurol; 2009 Mar; 5(3):140-52. PubMed ID: 19262590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
    Ma QL; Yang F; Rosario ER; Ubeda OJ; Beech W; Gant DJ; Chen PP; Hudspeth B; Chen C; Zhao Y; Vinters HV; Frautschy SA; Cole GM
    J Neurosci; 2009 Jul; 29(28):9078-89. PubMed ID: 19605645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies.
    Zhang Y; Chen J; Qiu J; Li Y; Wang J; Jiao J
    Am J Clin Nutr; 2016 Feb; 103(2):330-40. PubMed ID: 26718417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PUFA for prevention and treatment of dementia?
    Carrié I; Abellan Van Kan G; Rolland Y; Gillette-Guyonnet S; Vellas B
    Curr Pharm Des; 2009; 15(36):4173-85. PubMed ID: 20041819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?
    Cederholm T; Palmblad J
    Curr Opin Clin Nutr Metab Care; 2010 Mar; 13(2):150-5. PubMed ID: 20019606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Nutr Neurosci; 2012 Nov; 15(6):271-7. PubMed ID: 22824373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DHA may prevent age-related dementia.
    Cole GM; Frautschy SA
    J Nutr; 2010 Apr; 140(4):869-74. PubMed ID: 20181786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk.
    Devore EE; Grodstein F; van Rooij FJ; Hofman A; Rosner B; Stampfer MJ; Witteman JC; Breteler MM
    Am J Clin Nutr; 2009 Jul; 90(1):170-6. PubMed ID: 19474131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review.
    Canhada S; Castro K; Perry IS; Luft VC
    Nutr Neurosci; 2018 Oct; 21(8):529-538. PubMed ID: 28466678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet and Alzheimer's disease risk factors or prevention: the current evidence.
    Solfrizzi V; Panza F; Frisardi V; Seripa D; Logroscino G; Imbimbo BP; Pilotto A
    Expert Rev Neurother; 2011 May; 11(5):677-708. PubMed ID: 21539488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega 3 fatty acid for the prevention of cognitive decline and dementia.
    Sydenham E; Dangour AD; Lim WS
    Cochrane Database Syst Rev; 2012 Jun; (6):CD005379. PubMed ID: 22696350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease.
    Belkouch M; Hachem M; Elgot A; Lo Van A; Picq M; Guichardant M; Lagarde M; Bernoud-Hubac N
    J Nutr Biochem; 2016 Dec; 38():1-11. PubMed ID: 27825512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid facts, Part IV: docosahexaenoic acid and Alzheimer's disease. A story of mice, men and fish.
    Pauwels EK; Volterrani D; Mariani G; Kairemo K
    Drug News Perspect; 2009 May; 22(4):205-13. PubMed ID: 19536365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study.
    Lopez LB; Kritz-Silverstein D; Barrett Connor E
    J Nutr Health Aging; 2011 Jan; 15(1):25-31. PubMed ID: 21267518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.
    Gillette-Guyonnet S; Secher M; Vellas B
    Br J Clin Pharmacol; 2013 Mar; 75(3):738-55. PubMed ID: 23384081
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.